ARCHIVES

In Phase II Study, Vaccine IMA910 Stimulated Immune Response

This article is from The Cancer Letter archive.

Vol. 35 No. 2 | February 24, 2012

Download PDF Visit The Full Archive

Related Articles

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

Lymphoma Research Foundation names William Hawley president.

January 23, 2004

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

The Cancer Letter Wins Investigative Reporting Award

June 8, 2001

Hawaii Epidemiology Studies Offer Opportunities For Major Impact On Cancer Incidence, Survival

January 4, 1985

NCI Forms Lung Cancer Program for Research On Early Detection, Treatment.

June 23, 2006